Cargando…
Telemedicine in Overactive Bladder Syndrome
PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015147/ https://www.ncbi.nlm.nih.gov/pubmed/37193335 http://dx.doi.org/10.1007/s11884-023-00689-4 |
_version_ | 1784907154696699904 |
---|---|
author | Jericevic, Dora Brucker, Benjamin |
author_facet | Jericevic, Dora Brucker, Benjamin |
author_sort | Jericevic, Dora |
collection | PubMed |
description | PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the implementation of telemedicine across almost every medical specialty and (at least temporarily) swept away barriers including those regarding reimbursement and licensure. Telemedicine benefits patients and providers alike including savings on transportation costs, access to specialists or tertiary care from geographically remote locations, and minimized exposure to a contagious illness. Integration of telemedicine into clinical practice can reduce costs for office/exam space and staffing overhead, as well as facilitate greater scheduling efficiency. Many, if not most, aspects of care for the uncomplicated OAB patient can be as effectively managed remotely as with in-person encounters, across the treatment algorithm. SUMMARY: Telemedicine will almost certainly remain a key component in the care of OAB, general urology, and throughout all medical specialties. |
format | Online Article Text |
id | pubmed-10015147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-100151472023-03-15 Telemedicine in Overactive Bladder Syndrome Jericevic, Dora Brucker, Benjamin Curr Bladder Dysfunct Rep Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors) PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the implementation of telemedicine across almost every medical specialty and (at least temporarily) swept away barriers including those regarding reimbursement and licensure. Telemedicine benefits patients and providers alike including savings on transportation costs, access to specialists or tertiary care from geographically remote locations, and minimized exposure to a contagious illness. Integration of telemedicine into clinical practice can reduce costs for office/exam space and staffing overhead, as well as facilitate greater scheduling efficiency. Many, if not most, aspects of care for the uncomplicated OAB patient can be as effectively managed remotely as with in-person encounters, across the treatment algorithm. SUMMARY: Telemedicine will almost certainly remain a key component in the care of OAB, general urology, and throughout all medical specialties. Springer US 2023-03-15 2023 /pmc/articles/PMC10015147/ /pubmed/37193335 http://dx.doi.org/10.1007/s11884-023-00689-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors) Jericevic, Dora Brucker, Benjamin Telemedicine in Overactive Bladder Syndrome |
title | Telemedicine in Overactive Bladder Syndrome |
title_full | Telemedicine in Overactive Bladder Syndrome |
title_fullStr | Telemedicine in Overactive Bladder Syndrome |
title_full_unstemmed | Telemedicine in Overactive Bladder Syndrome |
title_short | Telemedicine in Overactive Bladder Syndrome |
title_sort | telemedicine in overactive bladder syndrome |
topic | Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015147/ https://www.ncbi.nlm.nih.gov/pubmed/37193335 http://dx.doi.org/10.1007/s11884-023-00689-4 |
work_keys_str_mv | AT jericevicdora telemedicineinoveractivebladdersyndrome AT bruckerbenjamin telemedicineinoveractivebladdersyndrome |